LH
Lars Hanan
OtherActivePartner at BroadOak Capital Partners
11
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Lars Hanan.
Investment Thesis & Strategy
BroadOak Capital Partners invests in various stages of biotech and fintech companies. They seek to partner with innovative companies with strong growth potential.
Investment Activity
Deals per year over the last 16 years
1
20000
20010
20020
20030
20041
20051
20060
20072
20080
20091
20100
20110
20121
20132
20141
2015Portfolio Companies
Selected investments from their portfolio of 11 companies
B
Bioinformatics
Biotech · Seed, 0
H
Halo Labs
Biotech · Series A, 2015
G
Genomenon
Biotech · Series B, 2014
C
Codex DNA
Biotech · Series A, 2014
s
seqWell
Biotech · Series A, 2013
I
InFuse Holdings
Healthcare · Seed, 2010
B
BioCision
Biotech · Seed, 2008
D
Diagnostic BioSystems
Biotech · Seed, 2008
E
Empire Genomics
Biotech · Seed, 2006
L
LabConnect
Healthcare · Growth, 2005
R
Rubicon Genomics
Biotech · Seed, 2000
Frequently Asked Questions
Lars Hanan focuses on Seed stage investments.